{"abstract":"The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry titled \"Pulmonary Tuberculosis: Developing Drugs for Treatment.\" The purpose of this guidance is to assist sponsors in the clinical development of new antibacterial drugs for the treatment of pulmonary tuberculosis (TB). This guidance finalizes the draft guidance of the same title issued on December 15, 2022.","action":"Notice of availability.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2026/05/11/2026-09269.html","cfr_references":[],"citation":"91 FR 25580","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"The announcement of the guidance is published in the Federal Register on May 11, 2026.","disposition_notes":null,"docket_ids":["Docket No. FDA-2013-D-1319"],"dockets":[],"document_number":"2026-09269","effective_on":null,"end_page":25582,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2026/05/11/2026-09269.xml","html_url":"https://www.federalregister.gov/documents/2026/05/11/2026-09269/pulmonary-tuberculosis-developing-drugs-for-treatment-guidance-for-industry-availability","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2026-09269?publication_date=2026-05-11","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2026-05-11/2026-09269/mods.xml","not_received_for_publication":null,"page_length":3,"page_views":{"count":165,"last_updated":"2026-08-26 22:15:05 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-05-11/pdf/2026-09269.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-09269.pdf?1778244315","publication_date":"2026-05-11","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2026/05/11/2026-09269.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_count":0,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2013-D-1319","supporting_documents_count":0,"docket_id":"FDA-2013-D-1319","document_id":"FDA-2013-D-1319-0015","regulation_id_number":null,"title":"Draft Guidance for Industry on Pulmonary Tuberculosis:  Developing Drugs for Treatment; Availability","checked_regulationsdotgov_at":"2026-05-12T12:55:04Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":25580,"subtype":null,"title":"Pulmonary Tuberculosis: Developing Drugs for Treatment; Guidance for Industry; Availability","toc_doc":"Pulmonary Tuberculosis: Developing Drugs for Treatment","toc_subject":"Guidance","topics":[],"type":"Notice","volume":91}